Wikipedia -WSS

Wikipedia

author：Wikipedia 2025-09-02 08:10:59 - browse：6679

Treeline Northwest — AP Photo/Ted S. Warren

Josh Bilenker’s last company, Loxo Oncology, was purchased by Eli Lilly for $8 billion. No surprise, then, that his next effort has already raised at least $473 million in funding from private investors even before telling the public what, exactly, it is working on.

Treeline Biosciences, the new venture by Bilenker and Jeffrey Engelman, formerly Novartis’s top cancer researcher, has hired more than 130 people across three research sites in little more than a year, according to a company blog post, regulatory filings, and STAT reporting.

Treeline’s website doesn’t mention a single drug target or disease. In a paper published last year in Nature Cancer, Engelman and several colleagues reviewed the history of a class of cancer drugs called PI3 kinase inhibitors.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Steward Health Care Massachusetts hospitals face fiscal disaster

leisure time

WSS

Readout LOUD podcast: ALS dilemma, first MASH drug, and more

5 ways to address the shortage of health care workers

FDA advisers back CAR

Steward Health Care Massachusetts hospitals face fiscal disaster

Male and female sex labels in research insufficient, scientists say

Bayer exec: U.S. is key in reviving beleaguered pharma’s drug pipeline

entertainment

Wikipedia

Wikipedia

Tori Bowie and the unacceptable rates of Black maternal death

NEJM study measures Covid brain fog, impact on IQ

Medicare proposal to cover medical devices draws a mixed reaction

Doctor of U.S. President Joe Biden says he is fit for duty

Hepatitis C has a cure — but many Americans still lack access to it

Children’s Hospital revives plan for pedestrian bridge

Moonlake's readout produced a cash windfall. Risks remain

Neuroscience renaissance leads to new crop of psychiatric drugs

Apple is now the first public company to be valued at $3 trillion

In boost for rare disease push, AstraZeneca to buy Amolyt Pharma

entertainment

HHS secretary Becerra pressed on Change HealthCare cyberattack

WuXi out of biotech trade group, U.S. and China relations to blame

'Vaccine

Pfizer is about to make a big push in cancer. Will investors listen?

John Green on his newest strategy for fighting tuberculosis

Neuroscience renaissance leads to new crop of psychiatric drugs

focus

leisure time

leisure time

focus